Breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 18-75 years; (2) Patients with breast cancer and epithelial ovarian cancer with definite pathological or histological diagnosis; (3) patients with breast cancer undergoing perioperative and postoperative adjuvant chemotherapy and hormone receptor-positive endocrine therapy in stage I-IIIA, Postoperative chemotherapy patients with ovarian cancer; (4) ECOG-PS 0-1; (5) Have a certain understanding and expression ability, voluntarily participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system; (2) pregnant women, breast-feeding, mental illness, mental and language disorders, and other mental disorders (such as strong) Obsessive-compulsive disorder, personality disorder, schizophrenia, bipolar disorder, etc.); (3) Patients with primary tumors in other parts; (4) Participate in other clinical trials within 3 months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptom cluster; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation index of tumor curative effect (progressive disease stable disease partial response complete response);Survival evaluation data (Overall Survival Progression-Free Survival Disease-Free Survival etc.); | — |
Countries
China
Contacts
Peking Union Medical College Hospital